
    
      This study is to evaluate whether PED-1 and PED2 are tolerable and effective in the treatment
      of premature ejaculation. The patients will be randomized and allocated to three treatment
      groups into placebo, PED-1, and PED-2. The creteria for IELT for enrollment will be > or =2
      min in the at least 75% of the sexual intercourse. To diagnosis premature ejaculation, the
      PEDT will be used. The patients ungone drug free baseline line period will take test drugs
      for 4 weeks.
    
  